RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
MULTIPLE SCLEROSIS (HOUNDMILLS, BASINGSTOKE, ENGLAND)
Collezione AOU San Luigi di Orbassano

Items : 13

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Mar;27(3):347-359. doi: 10.1177/1352458520952310. Epub 2020 Sep 17.

2021
AOU San Luigi di Orbassano

Scarpazza C; Puoti M; Prosperini L; Origoni M; Meroni L; Gerevini S; Galli M; Franzetti F; Comi G; Fasolo MM; Cinque P; Capra R; Capobianco M; Benatti SV; Barcella V; Riva A; Tortorella C; Zaffaroni M; Moiola L;

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Mar;27(3):331-346. doi: 10.1177/1352458520952311. Epub 2020 Sep 17.

2021
AOU San Luigi di Orbassano

Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; Gerevini S; Meroni L; Origoni M; Prosperini L; Puoti M; Scarpazza C; Tortorella C; Zaffaroni M; Riva A; Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; et alii...

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.

2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 May;25(6):856-866. doi: 10.1177/1352458518774935. Epub 2018 May 15.

2019
AOU San Luigi di Orbassano

Rosato R; Testa S; Bertolotto A; Scavelli F; Giovannetti AM; Confalonieri P; Patti F; Chisari CG; Lugaresi A; Pietrolongo E; Grasso MG; Rossi I; Toscano A; Loera B; Giordano A; Solari A;

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24.

2019
AOU San Luigi di Orbassano

Baroncini D; Zaffaroni M; Moiola L; Lorefice L; Fenu G; Iaffaldano P; Simone M; Fanelli F; Patti F; D'Amico E; Capobianco M; Bertolotto A; Gallo P; Margoni M; Miante S; Milani N; Amato MP; Righini I; Bellantonio P; Scandellari C; Costantino G; Scarpini E; Bergamaschi R; Mallucci G; Comi G; Ghezzi A;

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.

2019
AOU San Luigi di Orbassano

Lavie C; Rollot F; Durand-Dubief F; Marignier R; Ionescu I; Casey R; Moreau T; Tourniaire P; Hutchinson M; D'Hooghe MB; Laplaud DA; Clavelou P; De Sèze J; Debouverie M; Brassat D; Pelletier J; Lebrun-Frenay C; Le Page E; Castelnovo G; Berger E; Hautecoeur P; Heinzlef O; Durelli L; Clerico M; Trojano M; Patti F; Vukusic S;

e-Health and multiple sclerosis: An update. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19.

2018
AOU San Luigi di Orbassano

Lavorgna L; Brigo F; Moccia M; Leocani L; Lanzillo R; Clerico M; Abbadessa G; Schmierer K; Solaro C; Prosperini L; Tedeschi G; Giovannoni G; Bonavita S;

Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2017 May;23(6):874-876. doi: 10.1177/1352458516688350. Epub 2017 Feb 1.

2017
AOU San Luigi di Orbassano

Clerico M; De Mercanti S; Artusi CA; Durelli L; Naismith RT;

PML risk stratification using anti-JCV antibody index and L-selectin. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2016 Jul;22(8):1048-60. doi: 10.1177/1352458515607651. Epub 2015 Oct 2.

2016
AOU San Luigi di Orbassano

Comabella M; Kleinschnitz C; Jacobi A; Du Pasquier RA; Gold R; Zipp F; Meuth SG; Posevitz-Fejfár A; Montalban X; Luessi F; Siffrin V; Hohlfeld R; Kümpfel T; Cantó E; Breuer J; Windhagen S; Tackenberg B; Meinl I; Görlich D; Pignolet B; Spadaro M; Schneider-Hohendorf T; Schwab N; Bertolotto A; Brassat D; Wiendl H;

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2014 Aug;20(9):1265-8. doi: 10.1177/1352458514521311. Epub 2014 Feb 10.

2014
AOU San Luigi di Orbassano

Frisullo G; Calabrese M; Tortorella C; Paolicelli D; Ragonese P; Annovazzi P; Radaelli M; Malucchi S; Gallo A; Tomassini V; Nociti V; D'Onghia M; Lo Re V; Rodegher M; Solaro C; Gasperini C;

Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-? and interleukin-4 response. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2012 Oct;18(10):1484-92. doi: 10.1177/1352458512440349. Epub 2012 May 4.

2012
AOU San Luigi di Orbassano

Gilli F; Navone ND; Valentino P; Granieri L; Perga S; Malucchi S; Bertolotto A;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.

2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Dec;12(6):738-46. doi: 10.1177/1352458506070968.

2006
AOU San Luigi di Orbassano

Gilli F; Hoffmann F; Sala A; Marnetto F; Caldano M; Valentino P; Kappos L; Bertolotto A; Lindberg RL;